Scott B. Ullem, CVP, Chief Financial Officer at Edwards Lifesciences Corp (EW), sold 14,510 shares at $94.81 ($1.4M) on 2024-04-01, disclosed to the SEC on 2024-04-01.
Scheduled sale ($1.4M) by CVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.81 | 6,387 | $606K | 44.0% |
| 2 | $94.81 | 6,387 | $606K | 44.0% |
| 3 | $95.51 | 868 | $83K | 6.0% |
| 4 | $95.51 | 868 | $83K | 6.0% |
| Total | $94.89 avg | 14,510 | $1.4M | 100% |
| Filing → |
| EW | SELL | 2025-12-09 | $650K | — | Filing → |
| EW | SELL | 2025-11-10 | $2.2M | — | Filing → |
| EW | SELL | 2025-05-09 | $1.7M | — | Filing → |